當前位置:首頁>學者列表>醫學院(FMD) >鄭彥銘>發佈文章列表[所有]
排序方式:
    總頁 11 
      Go

    1.APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy (vol 15, pg 1031, 2021)

    Lau, G, Yu, ML, Wong     More...

    HEPATOLOGY INTERNATIONAL[1936-0533], Published 2022, Volume 16, Issue 2, Pages 486-487

    收錄情况: WOS SCOPUS

    2022影響因子:  6.6  发表年影響因子:  6.6 

    2.Achieving WHO target of HCV control in Hong Kong: challenges and strategies

    Wang, YD, Cheng, G,     More...

    GLOBAL HEALTH & MEDICINE[2434-9186], Published 2021, Volume 3, Issue 5, Pages 276-282

    收錄情况: WOS

    2022影響因子:  2.6 

    3.APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

    Lau, G, Yu, ML, Wong     More...

    HEPATOLOGY INTERNATIONAL[1936-0533], Published 2021, Volume 15, Issue 5, Pages 1031-1048

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 36  2022影響因子:  6.6  发表年影響因子:  9.046 

    4.Reply to: "NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression - The debate continues"

    Ji, D, Cheng, G, Lau     More...

    JOURNAL OF HEPATOLOGY[0168-8278], Published 2021, Volume 74, Issue 2, Pages 484-485

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2022影響因子:  25.7  发表年影響因子:  30.083 

    5.Letter to the Editor: Obesity, diabetes, non-alcoholic fatty liver disease and metabolic dysfunction associated fatty liver disease are proinflammatory hypercoagulable states associated with severe disease and thrombosis in Covid-19

    Ji, D, Zhang, MJ, Qi     More...

    METABOLISM-CLINICAL AND EXPERIMENTAL[0026-0495], Published 2021, Volume 115,

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 15  2022影響因子:  9.8  发表年影響因子:  13.934 

    6.The CALL Score for Predicting Outcomes in Patients With COVID-19 Reply

    Ji, D, Qin, EQ, Zhan     More...

    CLINICAL INFECTIOUS DISEASES[1058-4838], Published 2021, Volume 72, Issue 1, Pages 183-183

    收錄情况: WOS SCOPUS

    2022影響因子:  11.8  发表年影響因子:  20.999 

    7.The Inherent Problems With the Generalizability of the CALL Score: Towards Reliable Clinical Prediction Models for Coronavirus Disease 2019 (COVID-19) Reply

    Ji, D, Qin, EQ, Zhan     More...

    CLINICAL INFECTIOUS DISEASES[1058-4838], Published 2021, Volume 73, Issue 9, Pages E2819-E2819

    收錄情况: WOS SCOPUS

    2022影響因子:  11.8  发表年影響因子:  20.999 

    8.Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study

    DongJi, Guo-feng Che     More...

    Metabolism Open[2589-9368], Published 2021, Volume 10,

    9.Enhanced Protein Damage Clearance Induces Broad Drug Resistance in Multitype of Cancers Revealed by an Evolution Drug-Resistant Model and Genome-Wide siRNA Screening

    Shao, FY, Lyu, XY, M     More...

    ADVANCED SCIENCE[2198-3844], Published 2020, Volume 7, Issue 23,

    收錄情况: WOS SCOPUS

    WOS核心合集引用:  2022影響因子:  15.1  发表年影響因子:  16.806 

    10.Safety and efficacy of eltrombopag plus pulsed dexamethasone as first-line therapy for immune thrombocytopenia

    Zhang, LQ, Zhang, MJ     More...

    BRITISH JOURNAL OF HAEMATOLOGY[0007-1048], Published 2020, Volume 189, Issue 2, Pages 369-378

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 27  2022影響因子:  6.5  发表年影響因子:  6.998 

    11.Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study

    Ji, D, Qin, EQ, Xu,     More...

    JOURNAL OF HEPATOLOGY[0168-8278], Published 2020, Volume 73, Issue 2, Pages 451-453

    收錄情况: WOS SCOPUS

    2022影響因子:  25.7  发表年影響因子:  25.083 

    12.Reply to: 'No evidence for an increased liver uptake of SARS-CoV-2 in metabolic-associated fatty liver disease'

    Ji, D, Xu, J, Qin, E     More...

    JOURNAL OF HEPATOLOGY[0168-8278], Published 2020, Volume 73, Issue 3, Pages 718-719

    收錄情况: WOS SCOPUS

    2022影響因子:  25.7  发表年影響因子:  25.083 

    13.Management of COVID-19 in patients after liver transplantation: Beijing working party for liver transplantation

    Liu, HL, He, X, Wang     More...

    HEPATOLOGY INTERNATIONAL[1936-0533], Published 2020, Volume 14, Issue 4, Pages 432-436

    收錄情况: WOS SCOPUS

    2022影響因子:  6.6  发表年影響因子:  6.047 

    14.Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score

    Ji, D, Zhang, DW, Xu     More...

    CLINICAL INFECTIOUS DISEASES[1058-4838], Published 2020, Volume 71, Issue 6, Pages 1393-1399

    收錄情况: WOS SCOPUS

    2022影響因子:  11.8  发表年影響因子:  9.079 

    15.Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations

    Lau, G, Sharma, M

    HEPATOLOGY INTERNATIONAL[1936-0533], Published 2020, Volume 14, Issue 4, Pages 415-428

    收錄情况: WOS SCOPUS

    2022影響因子:  6.6  发表年影響因子:  6.047 

    16.Effect of COVID-19 on patients with compensated chronic liver diseases

    Ji, D, Zhang, DW, Ya     More...

    HEPATOLOGY INTERNATIONAL[1936-0533], Published 2020, Volume 14, Issue 5, Pages 701-710

    收錄情况: WOS SCOPUS

    2022影響因子:  6.6  发表年影響因子:  6.047 

    17.Achieving Treatment Free Prolonged Response in ITP patients Treated with Thrombopoietin Receptor Agonists (TPO-RAs)

    Lunqing Zhang, Mingj     More...

    Journal of Clinical Research and Medicine[2769-4275], Published 2020, Volume 3, Issue 2, Pages 1-2

    18.Recent advances on topical antimicrobials for skin and soft tissue infections and their safety concerns

    Lam, PL, Lee, KKH, W     More...

    CRITICAL REVIEWS IN MICROBIOLOGY[1040-841X], Published 2018, Volume 44, Issue 1, Pages 40-78

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 38  2022影響因子:  6.5  发表年影響因子:  5.697 

    19.Eltrombopag Plus Pulsed Dexamethasone As First Line Therapy for Subjects with Immune Thrombocytopenic Purpura (ITP)

    Zhang, LQ, Zhang, MJ     More...

    BLOOD[0006-4971], Published 2018, Volume 132,

    收錄情况: WOS

    WOS核心合集引用:  2022影響因子:  20.3  发表年影響因子:  16.601 

    20.Alzheimer's disease: insights for risk evaluation and prevention in the Chinese population and the need for a comprehensive programme in Hong Kong/China

    Yee, A, Tsui, NBY, C     More...

    HONG KONG MEDICAL JOURNAL[1024-2708], Published 2018, Volume 24, Issue 5, Pages 492-500

    收錄情况: WOS SCOPUS

    WOS核心合集引用: 13  2022影響因子:  2.7  发表年影響因子:  1.588 

    顯示      條  合計  211  條
      總頁 11 
        Go

      本系統需要使用 Internet Explorer 9.0 以上Firefox || Chrome瀏覽器

      Copyright © 2018 澳門科技大學學者庫